VYGR Q1 2026 Earnings Adjusted Loss Narrower Than Expected Despite No Revenue Satellos Bioscience Q1 2026 Earnings Narrower Loss Reported Stock Slips on Lack of Revenue Progress UZD Q1 2026 Earnings EPS Surges Past Estimates by 895 as Digital Infrastructure Demand Holds CRSP Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline Velocity Financial Q1 2026 Earnings EPS Beat Amid Modest Stock Pressure